Orion College ageing research receives 1 million UK pounds from Jim Mellon

18-May-2020
KEY POINTS FROM ARTICLE:

Jim Mellon donated £1 million to Oriel College for ageing research.
Through his company, Juvenescence, he supports ageing-focused biotech companies.
Already invested in rising stars such as Lygenesis, AgeX, and Insilico Medicine.
This donation establishes the Mellon Longevity Science Program.
And will directly support the research of Professor Lynne Cox.
It aims to advance research into health resilience in the elderly.
Cox lab studies molecular basis of human ageing to reduce age-related morbidity, frailty.
Includes researching therapies for strategies such as boosting the immune systems of older people.
Donation will also allow the creation of a DPhil scholarship in Aging and Cell Senescence at Oriel.
First recipient of the scholarship will join the College for the 2020-21 academic year.
Mellon commended Oxford’s leadership in the field of research and understanding of ageing.
Making it a natural home to advance longevity science and support growth of its industry.

He believes in the importance of boosting immunoresilience among elderly

Mentioned in this article:

Resource AgeX Therapeutics

Resource Insilico Medicine

Resource Jim Mellon

Resource Juvenescence - Developing therapies against different aging related diseases.

Resource LyGenesis

Resource Lynne Cox - Molecular cell biologist studying the biology of ageing and age-related diseases.

Resource Oriel College - Constituent college of the University of Oxford

Resource University of Oxford - Oxford is one of the world's leading universities

Read full article on Life Extension Advocacy Foundation (LEAF) website
More Ageing Research information, news and resources
More Longevity Industry Investments information, news and resources